סיטאגמט אס. קיי 1000 מג 50  מג ישראל - עברית - Ministry of Health

סיטאגמט אס. קיי 1000 מג 50 מג

k.s.kim international (sk- pharma) ltd., israel - metformin hydrochloride; sitagliptin - טבליות מצופות פילם - metformin hydrochloride 1000 mg; sitagliptin 50 mg - metformin and sitagliptin

סיטאגמט אס. קיי 850 מג 50  מג ישראל - עברית - Ministry of Health

סיטאגמט אס. קיי 850 מג 50 מג

k.s.kim international (sk- pharma) ltd., israel - metformin hydrochloride; sitagliptin - טבליות מצופות פילם - metformin hydrochloride 850 mg; sitagliptin 50 mg - metformin and sitagliptin

סיטאפורמין טבע 50 מג1000 מג ישראל - עברית - Ministry of Health

סיטאפורמין טבע 50 מג1000 מג

teva israel ltd - metformin hydrochloride; sitagliptin as malate - טבליות מצופות פילם - metformin hydrochloride 1000 mg; sitagliptin as malate 50 mg - metformin and sitagliptin

סיטאפורמין טבע 50 מג500 מג ישראל - עברית - Ministry of Health

סיטאפורמין טבע 50 מג500 מג

teva israel ltd - metformin hydrochloride; sitagliptin as malate - טבליות מצופות פילם - metformin hydrochloride 500 mg; sitagliptin as malate 50 mg - metformin and sitagliptin

סיטאפורמין טבע 50 מג850 מג ישראל - עברית - Ministry of Health

סיטאפורמין טבע 50 מג850 מג

teva israel ltd - metformin hydrochloride; sitagliptin as malate - טבליות מצופות פילם - metformin hydrochloride 850 mg; sitagliptin as malate 50 mg - metformin and sitagliptin

אפודיקס קרם % 5 ישראל - עברית - Ministry of Health

אפודיקס קרם % 5

megapharm ltd - fluorouracil - קרם - fluorouracil 50 mg / 1 g - pyrimidine analogues - antineoplastic agent to treat actinic keratosis multiple and superfacial basel cell carcinoma.

ג'נואט 50/1000 מ"ג טבליות ישראל - עברית - Ministry of Health

ג'נואט 50/1000 מ"ג טבליות

merck sharp & dohme israel ltd - metformin hydrochloride 1000 mg; sitagliptin as monohydrate phosphate 50 mg - tablets - metformin - januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. important limitations of use:januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.januet has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januet.

ג'נואט 50/1000 מ"ג טבליות ישראל - עברית - Ministry of Health

ג'נואט 50/1000 מ"ג טבליות

merck sharp & dohme israel ltd - metformin hydrochloride 1000 mg; sitagliptin as monohydrate phosphate 50 mg - tablets - metformin - januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. important limitations of use:januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.januet has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januet.

ג'נואט 50/1000 מ"ג טבליות ישראל - עברית - Ministry of Health

ג'נואט 50/1000 מ"ג טבליות

merck sharp & dohme israel ltd - metformin hydrochloride 1000 mg; sitagliptin as monohydrate phosphate 50 mg - tablets - metformin - januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. important limitations of use:januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.januet has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januet.

ג'נואט 50/1000 מ"ג טבליות ישראל - עברית - Ministry of Health

ג'נואט 50/1000 מ"ג טבליות

merck sharp & dohme israel ltd - metformin hydrochloride 1000 mg; sitagliptin as monohydrate phosphate 50 mg - tablets - metformin - januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. important limitations of use:januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.januet has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januet.